查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1370952

基因組學市場中的區塊鏈 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按業務模式、服務、按應用、最終用戶、地區和競爭細分

Blockchain in Genomics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Business Model, By Service, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 189 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022 年全球區塊鏈基因組市場價值為 10.6 億美元，預計在預測期內將實現強勁成長，年複合成長率 (CAGR) 為 11.11%，預計到 2028 年將達到 19.8 億美元。數位化公共分類帳將交易和資料記錄為區塊，提供了一個分散的網路，用於跨互連的資料庫系統分發資料。它透過適當的授權實現全球訪問，使用戶能夠控制資料分發以保護隱私。利用非對稱加密技術透過加密增強資料安全性。出售或捐贈資料時，接收者會收到用於獨佔存取的私有解密金鑰，從而防止未經授權的入侵。區塊鏈促進基因組資料的儲存、管理和交換。其去中心化模式有利於銀行、金融、生物製藥和基因組研究等產業。在這些產業中，區塊鏈促進基因組資料提供者和客戶之間的交易和支付，幫助決策。區塊鏈平台促進資料提供者（用戶）和買家（包括製藥公司和研究機構）之間的直接互動。

主要市場促進因素

私人投資者和創投家的投資不斷增加

市場概況
預測期 2024-2028
2022 年市場規模 10.6億美元
2028 年市場規模 19.8億美元
2023-2028 年年複合成長率 11.11%
成長最快的細分市場 製藥與生物技術公司
最大的市場 北美洲

增加投資使研究人員和創新者能夠探索和開發專為基因組學量身定做的區塊鏈解決方案。這筆資金支持利用區塊鏈功能的新平台、工具和應用程式。私人參與者和創投家加速基因組學區塊鏈解決方案的開發。這會帶來更快的技術進步，使區塊鏈更容易存取並適用於基因組研究和資料管理。資金支持創建強大且可擴展的區塊鏈基礎設施，以安全處理大量基因組資料。投資促進利害關係人之間的合作，包括研究人員、產業參與者、技術提供者和醫療機構。風險資本投資推動了專注於基因組學的新創公司開發區塊鏈解決方案的成長。這些新創公司為新平台、工具和應用程式做出了貢獻，增加了對區塊鏈技術的需求。區塊鏈投資簡化了臨床試驗、資料共享和研究協作，提高了基因組學研究的效率。

基因組學的不斷發展

區塊鏈的去中心化和安全性可以保護基因組資料免於未經授權的存取和洩露，從而確保病患隱私。它使個人能夠控制基因組資料的訪問，授予或撤銷與研究人員或醫療保健提供者共享的許可。區塊鏈建立了安全平台，用於跨多個實體共享和存取基因組資料，同時保持資料完整性。隨著時間的推移，不變性可確保資料的準確性和可靠性。

數位工具的採用不斷增加

區塊鏈技術中的數位工具增強了基因組資料的加密和安全性，確保機密性和保護。它們能夠為基因組學研究中的個人創建和管理分散的身份，控制對個人基因組資料的存取。數位工具標準化了區塊鏈上基因組資料的格式和元數據，促進資料檢索和分析。它們可以在研究人員、醫療保健提供者和患者之間安全共享基因組資料，允許參與者定義存取權限並追蹤資料使用情況。數位工具透過在區塊鏈上記錄資料雜湊或數位簽章來驗證基因組資料的完整性。它們可以即時追蹤資料交易，提高透明度和可追溯性。

病患醫療服務數位化

區塊鏈被認為是資料所有者和用戶（例如研究團體和製藥公司）之間值得信賴的交易方式。平台可以輕鬆存取基因組資料集，改善個人化藥物和治療研究的資訊採購。許多公司推廣區塊鏈來管理遺傳資訊。製藥企業和政府機構的策略合作夥伴關係以及風險資本投資表明，區塊鏈平台用於遺傳資料儲存和管理的接受度越來越高。

主要市場挑戰

監管挑戰

由於基因組資料的獨特性、資料隱私問題、資料所有權以及區塊鏈的去中心化性質，出現了監管挑戰。基因組資料的敏感性需要遵守資料隱私原則，這給獲得區塊鏈儲存和使用的知情和明確同意帶來了挑戰。確定資料所有權並在去中心化區塊鏈上主張權利非常複雜。適應或創建適應區塊鏈特徵的新法規至關重要。

缺乏資源和利害關係人

資源和熟練專業人員的稀缺可能會阻礙區塊鏈解決方案的開發。需要金融投資、密碼學和智慧合約方面的技術專業知識以及強大的基礎設施。缺乏資金可能會阻礙安全且可擴展的平台創建。為確保互通性和資料完整性，必須建立資料格式、術語和元資料標準。

主要市場趨勢

技術創新

區塊鏈創新可以增強資料安全、隱私功能和同意管理。這鼓勵資料貢獻和研究參與。創新平台可以建立安全的跨境資料共享和協作，加快研究步伐。不斷發展的區塊鏈技術和創新將推動其在基因組學中的採用。

推出新的基於區塊鏈的平台

專用平台可以應對挑戰並為資料共享、研究和個人化醫療創造環境。基因組學資料的客製化資料管理解決方案可以確保安全儲存、共享和追蹤，增強資料完整性和隱私性。這些平台可以整合隱私功能和同意管理，鼓勵資料貢獻和參與。

細分市場洞察

商業模式見解

企業對客戶 (B2C) 領域在 2020 年基因組學市場的全球區塊鏈中佔據主導地位。企業和中小企業採用 B2C 模式有助於收入成長。區塊鏈為 B2C 公司提供安全的數位貨幣交易和獨特的基因組資料處理。

應用洞察

資料共享和貨幣化領域預計將經歷最高的收入成長率。區塊鏈可以實現基因組資料的安全共享和貨幣化，從而加速研究和個人化醫療。

區域洞察

由於遺傳性疾病盛行率上升、研發活動、區塊鏈採用、政府對醫療保健研發的投資以及市場參與者的存在，北美在 2022 年引領全球基因組學市場的區塊鏈。 GenoBank.io Inc.、LunaDNA、Longenesis Ltd. 和 Nebula Genomics, Inc. 等知名公司正在為區域市場的成長做出貢獻。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：基因組學市場展望中的全球區塊鏈

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依商業模式（B2B商業模式、B2C商業模式、C2B商業模式）
    • 按服務（實用代幣和區塊鏈平台）
    • 按應用（數據共享和貨幣化、數據存儲和安全以及自動化健康保險）
    • 按最終用戶（製藥和生物技術公司、醫院和醫療保健提供者、研究機構、數據所有者等）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美基因組學市場展望中的區塊鏈

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按商業模式
    • 按服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲基因組學市場展望中的區塊鏈

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按商業模式
    • 按服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區區塊鏈在基因組學市場前景

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按商業模式
    • 按服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲基因組學市場展望中的區塊鏈

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按商業模式
    • 按服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲基因組學市場展望中的區塊鏈

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按商業模式
    • 按服務
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非基因組學區塊鏈
    • 沙烏地阿拉伯基因組學區塊鏈
    • 阿拉伯聯合大公國區塊鏈在基因體學的應用

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球口腔臨床營養市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • Digital DNAtix Ltd.
    • Encrypgen Incorporated
    • Genobank.io Inc.
    • Genomes.io
    • Longenesis
    • LunaDNA, LLC
    • Nebula Genomics, Inc.
    • Shivom Ventures Limited
    • SimplyVital Health, Inc.
    • WuXi Nextcode Genomics, Inc.

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 4660

The Global Blockchain in Genomics Market was valued at USD 1.06 Billion in 2022 and is projected to experience robust growth during the forecast period, with a Compound Annual Growth Rate (CAGR) of 11.11% and expected to reach USD 1.98 Billion through 2028. Blockchain, a digitized public ledger recording transactions and data as blocks, offers a decentralized network for distributing data across interconnected database systems. It enables global accessibility with proper authorization, providing users control over data distribution to safeguard privacy. Utilizing asymmetric cryptography enhances data security through encryption. When selling or donating data, recipients receive a private decryption key for exclusive access, preventing unauthorized intrusion. Blockchain facilitates the storage, management, and exchange of genomic data. Its decentralized model benefits sectors such as banking, finance, biopharmaceuticals, and genomic research. In these industries, blockchain facilitates transactions and payments between genomic data providers and customers, aiding decision-making. The blockchain platform fosters direct interaction between data providers (users) and buyers, including pharmaceutical firms and research institutes.

Key Market Drivers

Rising Investment by Private Players and Venture Capitalists

Market Overview
Forecast Period2024-2028
Market Size 2022USD 1.06 Billion
Market Size 2028USD 1.98 Billion
CAGR 2023-202811.11%
Fastest Growing SegmentPharmaceutical & Biotechnology Companies
Largest MarketNorth America

Increased investment empowers researchers and innovators to explore and develop blockchain solutions tailored for genomics. This funding supports new platforms, tools, and applications harnessing blockchain's capabilities. Private players and venture capitalists accelerate blockchain solution development for genomics. This leads to quicker technological advancements, making blockchain more accessible and applicable to genomic research and data management. Funding supports the creation of robust and scalable blockchain infrastructure for secure handling of large volumes of genomic data. Investments foster collaboration among stakeholders, including researchers, industry players, technology providers, and healthcare institutions. Venture capital investment drives growth in genomics-focused startups developing blockchain solutions. These startups contribute to new platforms, tools, and applications, increasing demand for blockchain technology. Blockchain investment streamlines clinical trials, data sharing, and research collaboration, enhancing efficiency in genomics research.

Increasing Developments in Genomics

Blockchain's decentralized and secure nature can protect genomic data from unauthorized access and breaches, ensuring patient privacy. It empowers individuals to control genomic data access, granting or revoking permission for sharing with researchers or healthcare providers. Blockchain establishes secure platforms for sharing and accessing genomic data across multiple entities while maintaining data integrity. Immutability ensures data accuracy and reliability over time.

Rising Adoption of Digital Tools

Digital tools in blockchain technology enhance encryption and security for genomic data, ensuring confidentiality and protection. They enable creation and management of decentralized identities for individuals in genomics research, controlling access to personal genomic data. Digital tools standardize formats and metadata for genomic data on the blockchain, facilitating data retrieval and analysis. They enable secure sharing of genomic data among researchers, healthcare providers, and patients, allowing participants to define access permissions and track data usage. Digital tools verify genomic data integrity by recording data hashes or digital signatures on the blockchain. They enable real-time tracking of data transactions, enhancing transparency and traceability.

Digitization of Healthcare Services by Patients

Blockchain is considered a trusted means of transactions between data owners and users, such as research groups and pharmaceutical companies. Platforms offer easy access to genomic datasets, improving information procurement for personalized drug and therapy research. Numerous companies promote blockchain for managing genetic information. Strategic partnerships involving pharmaceutical players and government bodies, along with venture capital investments, indicate growing acceptance of blockchain platforms for genetic data storage and management.

Key Market Challenges

Regulatory Challenges

Regulatory challenges arise due to the unique nature of genomic data, data privacy concerns, data ownership, and the decentralized nature of blockchain. Genomic data sensitivity requires adherence to data privacy principles, posing challenges in obtaining informed and explicit consent for blockchain storage and usage. Determining data ownership and asserting rights on a decentralized blockchain is complex. Adapting or creating new regulations accommodating blockchain's characteristics is crucial.

Lack of Resources and Stakeholders

Scarcity of resources and skilled professionals can hinder blockchain solution development. Financial investment, technical expertise in cryptography and smart contracts, and robust infrastructure are required. Lack of funding can impede secure and scalable platform creation. Established standards for data formats, terminologies, and metadata are necessary to ensure interoperability and data integrity.

Key Market Trends

Innovations in Technology

Blockchain innovations can enhance data security, privacy features, and consent management. This encourages data contribution and research participation. Innovative platforms can establish secure cross-border data sharing and collaboration, accelerating research pace. Evolving blockchain technology and innovations will drive its adoption in genomics.

Launch of New Blockchain-Based Platforms

Dedicated platforms can address challenges and create environments for data sharing, research, and personalized medicine. Customized data management solutions for genomics data can ensure secure storage, sharing, and tracking, enhancing data integrity and privacy. These platforms can integrate privacy features and consent management, encouraging data contribution and participation.

Segmental Insights

Business Model Insights

The Business to Customer (B2C) segment dominated the global blockchain in genomics market in 2020. Adoption of B2C models by enterprises and SMEs aids revenue growth. Blockchain facilitates secure digital currency transactions and unique genomic data processing for B2C companies.

Application Insights

The data sharing and monetization segment is expected to experience the highest revenue growth rate. Blockchain enables secure sharing and monetization of genomic data, accelerating research and personalized medicine.

Regional Insights

North America led the global blockchain in genomics market in 2022 due to rising genetic disorder prevalence, R&D activities, blockchain adoption, government investments in healthcare R&D, and presence of market players. Prominent companies, such as GenoBank.io Inc., LunaDNA, Longenesis Ltd., and Nebula Genomics, Inc., are contributing to regional market growth.

Key Market Players

  • Digital DNAtix Ltd.
  • Encrypgen Incorporated
  • Genobank.io Inc.
  • Genomes.io
  • Longenesis
  • LunaDNA, LLC
  • Nebula Genomics, Inc.
  • Shivom Ventures Limited
  • SimplyVital Health, Inc.
  • WuXi Nextcode Genomics, Inc.

Report Scope:

In this report, the Global Blockchain in Genomics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below.

Blockchain in Genomics Market, By Business Model:

  • B2B Business Model
  • B2C Business Model
  • C2B Business Model

Blockchain in Genomics Market, By Service:

  • Utility Tokens
  • Blockchain Platforms

Blockchain in Genomics Market, By Application:

  • Data Sharing & Monetization
  • Data Storage & Security
  • Automated Health Insurance

Blockchain in Genomics Market, By End User:

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Healthcare Providers
  • Research Institutes
  • Data Owners
  • Others

Blockchain in Genomics Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Blockchain in Genomics Market.

Available Customizations:

  • Global Blockchain in Genomics market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blockchain in Genomics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Business Model (B2B Business Model, B2C Business Model, and C2B Business Model)
    • 5.2.2. By Service (Utility Tokens and Blockchain Platforms)
    • 5.2.3. By Application (Data Sharing & Monetization, Data Storage & Security, and Automated Health Insurance)
    • 5.2.4. By End User (Pharmaceutical & Biotechnology Companies, Hospitals & Healthcare Providers, Research Institutes, Data Owners, And Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (2022)
  • 5.3. Market Map

6. North America Blockchain in Genomics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Business Model
    • 6.2.2. By Service
    • 6.2.3. By Application
    • 6.2.4. By End User
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Blockchain in Genomics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Business Model
        • 6.3.1.2.2. By Service
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End User
    • 6.3.2. Canada Blockchain in Genomics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Business Model
        • 6.3.2.2.2. By Service
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End User
    • 6.3.3. Mexico Blockchain in Genomics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Business Model
        • 6.3.3.2.2. By Service
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End User

7. Europe Blockchain in Genomics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Business Model
    • 7.2.2. By Service
    • 7.2.3. By Application
    • 7.2.4. By End User
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Blockchain in Genomics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Business Model
        • 7.3.1.2.2. By Service
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End User
    • 7.3.2. United Kingdom Blockchain in Genomics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Business Model
        • 7.3.2.2.2. By Service
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End User
    • 7.3.3. Italy Blockchain in Genomics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Business Model
        • 7.3.3.2.2. By Service
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End User
    • 7.3.4. France Blockchain in Genomics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Business Model
        • 7.3.4.2.2. By Service
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End User
    • 7.3.5. Spain Blockchain in Genomics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Business Model
        • 7.3.5.2.2. By Service
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End User

8. Asia-Pacific Blockchain in Genomics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Business Model
    • 8.2.2. By Service
    • 8.2.3. By Application
    • 8.2.4. By End User
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Blockchain in Genomics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Business Model
        • 8.3.1.2.2. By Service
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End User
    • 8.3.2. India Blockchain in Genomics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Business Model
        • 8.3.2.2.2. By Service
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End User
    • 8.3.3. Japan Blockchain in Genomics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Business Model
        • 8.3.3.2.2. By Service
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End User
    • 8.3.4. South Korea Blockchain in Genomics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Business Model
        • 8.3.4.2.2. By Service
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End User
    • 8.3.5. Australia Blockchain in Genomics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Business Model
        • 8.3.5.2.2. By Service
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End User

9. South America Blockchain in Genomics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Business Model
    • 9.2.2. By Service
    • 9.2.3. By Application
    • 9.2.4. By End User
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Blockchain in Genomics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Business Model
        • 9.3.1.2.2. By Service
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End User
    • 9.3.2. Argentina Blockchain in Genomics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Business Model
        • 9.3.2.2.2. By Service
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End User
    • 9.3.3. Colombia Blockchain in Genomics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Business Model
        • 9.3.3.2.2. By Service
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End User

10. Middle East and Africa Blockchain in Genomics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Business Model
    • 10.2.2. By Service
    • 10.2.3. By Application
    • 10.2.4. By End User
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Blockchain in Genomics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Business Model
        • 10.3.1.2.2. By Service
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End User
    • 10.3.2. Saudi Arabia Blockchain in Genomics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Business Model
        • 10.3.2.2.2. By Service
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End User
    • 10.3.3. UAE Blockchain in Genomics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Business Model
        • 10.3.3.2.2. By Service
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Oral Clinical Nutrition Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. Digital DNAtix Ltd.
    • 15.5.2. Encrypgen Incorporated
    • 15.5.3. Genobank.io Inc.
    • 15.5.4. Genomes.io
    • 15.5.5. Longenesis
    • 15.5.6. LunaDNA, LLC
    • 15.5.7. Nebula Genomics, Inc.
    • 15.5.8. Shivom Ventures Limited
    • 15.5.9. SimplyVital Health, Inc.
    • 15.5.10. WuXi Nextcode Genomics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer